IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 348 filers reported holding IONIS PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.32 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $7,127 | +7.9% | 161 | 0.0% | 0.00% | +100.0% |
| Q2 2023 | $6,606 | +14.8% | 161 | 0.0% | 0.00% | 0.0% |
| Q1 2023 | $5,754 | -18.5% | 161 | -13.9% | 0.00% | -50.0% |
| Q4 2022 | $7,063 | -11.7% | 187 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $8,000 | +14.3% | 187 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $7,000 | 0.0% | 187 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $7,000 | +16.7% | 187 | 0.0% | 0.00% | +100.0% |
| Q4 2021 | $6,000 | -94.4% | 187 | -94.1% | 0.00% | -96.0% |
| Q3 2021 | $107,000 | -15.7% | 3,187 | 0.0% | 0.02% | -10.7% |
| Q2 2021 | $127,000 | -65.5% | 3,187 | -61.1% | 0.03% | -68.9% |
| Q1 2021 | $368,000 | -21.5% | 8,187 | -1.4% | 0.09% | -28.6% |
| Q4 2020 | $469,000 | +216.9% | 8,302 | +166.5% | 0.13% | +152.0% |
| Q3 2020 | $148,000 | -16.4% | 3,115 | +3.8% | 0.05% | -28.6% |
| Q2 2020 | $177,000 | – | 3,000 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tweedy, Browne Co LLC | 3,510,173 | $159,221,447 | 8.52% |
| Bellevue Group AG | 9,233,700 | $418,840,632 | 6.75% |
| Deep Track Capital, LP | 2,834,069 | $128,553,370 | 4.96% |
| BVF INC/IL | 4,004,613 | $181,649,246 | 4.90% |
| Sicart Associates LLC | 203,132 | $9,214,068 | 3.61% |
| Camber Capital Management LP | 2,250,000 | $102,060 | 3.36% |
| Privium Fund Management B.V. | 228,493 | $10,364,443 | 3.08% |
| Orbimed Advisors | 2,169,500 | $98,408,520 | 2.09% |
| SECTOR GAMMA AS | 165,616 | $7,512,342 | 1.92% |
| TANAKA CAPITAL MANAGEMENT INC | 14,612 | $663 | 1.89% |